Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival

Neuro-Oncology

Volumn 15, Issue 12, 2013, Pages 1710-1720

  Teng, Lei ^a,b   Nakada, Mitsutoshi ^a   Furuyama, Natsuki ^a   Sabit, Hemragul ^c   Furuta, Takuya ^a   Hayashi, Yutaka ^a   Takino, Takahisa ^c   Dong, Yu ^a,b   Sato, Hiroshi ^c   Sai, Yoshimichi ^a   Miyamoto, Ken Ichi ^a   Berens, Michael E ^d   Zhao, Shi Guang ^b   Hamada, Jun Ichiro ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^c Centre for Cancer Research Institute   (Japan)

^d TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

Eph ephrin; Glioma; Invasion; Migration; Tyrosine kinase

Indexed keywords

EPHRIN B1; EPHRIN B2; IMMUNOGLOBULIN FC FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; AUTOPHOSPHORYLATION; BRAIN BIOPSY; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL MIGRATION ASSAY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; SURVIVAL RATE; TUMOR INVASION;

EPH-EPHRIN; GLIOMA; INVASION; MIGRATION; TYROSINE KINASE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN; BRAIN NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; EPHRIN-B1; EPHRIN-B2; FEMALE; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; LIGANDS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM GRADING; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84891857620     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not128     Document Type: Article

References (36)

1. Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer. 2003;3(7):489-501.
2. Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME. Molecular targets of glioma invasion. Cell Mol Life Sci. 2007;64(4):458-478.
3. Morokoff AP, Novak U. Targeted therapy for malignant gliomas. J Clin Neurosci. 2004;11(8):807-818.
4. Ducray F. Chemotherapy for diffuse low-grade gliomas in adults. Revue Neurologique. 2011;167(10):673-679.
5. Drappatz J, Norden AD,Wen PY. Therapeutic strategies for inhibiting invasion in glioblastoma. Expert Rev Neurother. 2009;9(4):519-534.
6. Flanagan JG, GaleNW, Hunter T, Pasquale EB, TessierLavigne M. Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell. 1997;90(3):403-404.
7. Nakada M, Anderson EM, Demuth T, et al. The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion. Int J Cancer. 2010;126(5):1155-1165.
8. Pasquale EB. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol. 2005;6(6):462-475.
9. Wilkinson DG. Multiple roles ofEPH receptors and ephrins in neural development. Nat Rev Neurosci. 2001;2(3):155-164.
10. Heroult M, Schaffner F, Augustin HG. Eph receptor and ephrin ligandmediated interactions during angiogenesis and tumor progression. Exp Cell Res. 2006;312(5):642-650.
11. Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell. 2008;133(1):38-52.
12. Campbell TN, Robbins SM. The Eph receptor/ephrin system: An emerging player in the invasion game. Curr Issues Mol Biol. 2008;10(1-2):61-66.
13. Wang SD, Rath P, Lal B, et al. EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase. Oncogene. 2012;30(50):5132-5143.
14. Noren NK, YangNY, Silldorff M, Mutyala R, Pasquale EB. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor. Biochem J. 2009;422(3):433-442.
15. Miao H, Li DQ, Mukherjee A, et al. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cellmigration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell. 2009;16(1):9-20.
16. Genander M, Halford MM, Xu NJ, et al. Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression. Cell. 2009;139(4):679-692.
17. Chen J, Zhuang G, Frieden L, Debinski W. Eph receptors and ephrins in cancer: common themes and controversies. Cancer Res. 2008;68(24): 10031-10033.
18. Nakada M,Niska JA, Tran NL, McDonough WS,Berens ME. EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion. Am J Pathol. 2005;167(2):565-576.
19. Nakada M, Niska JA, Miyamori H, et al. The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells. Cancer Res. 2004;64(9):3179- 185.
20. Batlle E, Bacani J, Begthel H, et al. EphB receptor activity suppresses colorectal cancer progression. Nature. 2005;435(7045):1126-1130.
21. Huusko P, Ponciano-Jackson D,Wolf M, et al. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nat Genet. 2004;36(9):979-983.
22. Noren NK, Pasquale EB. Paradoxes of the EphB4 receptor in cancer. Cancer Res. 2007;67(9):3994-3997.
23. Madhavan S, Zenklusen JC, Kotliarov Y, Sahni H, Fine HA, Buetow K. REMBRANDT: helping personalized medicine become a reality through integrative translational research. Mol Cancer Res. 2009;7(2): 157-167.
24. Nakada M, Drake KL, Nakada S, Niska JA, Berens ME. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1. Cancer Res. 2006;66(17):8492-8500.
25. YoshidaY, NakadaM,Sugimoto N, et al. Sphingosine-1-phosphate receptor type 1 regulates glioma cell proliferation and correlates with patient survival. Int J Cancer. 2009;126(10):2341-2352.
26. Okamoto H, Takuwa N, Yokomizo T, et al. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol Cell Biol. 2000;20(24):9247-9261.
27. Teng L, Nakada M, Zhao SG, et al. Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy. Br J Cancer. 2011;104(5):798-807.
28. MacDonald IJ, Dougherty TJ. Basic principles of photodynamic therapy. J Porphyr Phthalocya. 2001;5(2):105-129.
29. Brantley-Sieders DM. Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling. Semin Cell Dev Biol. 2012;23(1):102-108.
30. Ji XD, Li G, Feng YX, et al. EphB3 is overexpressed in non-small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migration. Cancer Res. 2011;71(3):1156-1166.
31. Tu YY, He SM, Fu JF, et al. Expression of ephrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients. Clin Transl Oncol. 2012;14(3):214-220.
32. Sheng Z, Wang JD, Dong YC, et al. EphB1 is underexpressed in poorly differentiated colorectal cancers. Pathobiology. 2008;75(5): 274-280.
33. Wang JD, Dong YC, Sheng Z, et al. Loss of expression of EphB1 protein in gastric carcinoma associated with invasion and metastasis. Oncology. 2007;73(3-4):238-245.
34. Bochenek ML, Dickinson S, Astin JW, Adams RH, Nobes CD. Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding. J Cell Sci. 2010;123(Pt 8):1235-1246.
35. Cowan CA, Henkemeyer M. The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals. Nature. 2001;413(6852):174-179.
36. Foo SS, Turner CJ, Adams S, et al. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell. 2006;124(1): 161-173.